Helen Papadaki is a Professor of Haematology at the School of Medicine, University of Crete (UoC), Greece. She is Head of the Department of Haematology, Cell Therapy Unit and the Public Cord Blood Bank of the University Hospital of Heraklion, Crete, and Head of the Haemopoiesis Research Laboratory, UoC.
Dr. Papadaki received her MD from the UoAthens with honours and her PhD from the UoC. She has been trained in Internal Medicine and Haematology at the UoC and has been post-doc researcher (EMBO fellowship) in Saint George’s Medical School, London, UK, visiting scientist at the Institute for Cancer Studies, Birmingham, UK and visiting physician at the Department of Haematology, University of Washington, Seattle, USA.
Dr Papadaki has been appointed Deputy Rector of the UoC (2013-2015), has been elected as European Haematology Association (EHA) Board Member (2016 – 2020), she is now co-chairing the EHA Community and Stakeholder Committee and is a member of the EHA Good Governance Committee. She is the co-chair of the EHA Scientific Working Group on Granulocyte and Constitutional Marrow Failure Syndromes, external advisory board member of the Severe Chronic Neutropenia International Registry (SCNIR).
Education
| 1991 – 1995 | PhD in Medicine (with honors), Faculty of Medicine, University of Crete, Greece (Thesis title: The role of soluble IL-6R in Multiple Myeloma, Degree 10) |
| 1989 – 1995 | Specialization in Haematology, Department of Haematology, University Hospital of Heraklion, Crete, Greece |
| 1981 – 1987 | MD (with honors), Faculty of Medicine, University of Athens, Greece |
Research Interests
Publications
Memberships
| 1995 – today | Memberships
Hellenic Society of Haematology European Society of Haematology (EHA); American Society of Haematology (ASH); Hellenic Society of Gene Therapy and Regenerative Medicine (General Secretary) |
